ORMP fundamentals
An in-depth look to ORAMED PHARM operating, investing, and financing activities
ORMP free cash flow for Q1 24 is -5.46 M ILS. For 2023, ORMP free cash flow was -38.3 M ILS and operating cash flow was -37.38 M ILS.
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: ILS
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM